CYB5D2 and cervical cancer: GEO database analysis reveals differential expression of immune checkpoint molecules (such as GZMB, IFNG, FOXP3) during the progression of cervical cancer, suggesting CYB5D2 modulates the tumor immune microenvironment by regulating the infiltration of immune cells into tumor tissues and thereby affecting the prognosis of patients.